PortfoliosLab logoPortfoliosLab logo
RCEL vs. ORI
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

RCEL vs. ORI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AVITA Medical, Inc. (RCEL) and Old Republic International Corporation (ORI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, RCEL achieves a 20.58% return, which is significantly higher than ORI's -13.49% return.


RCEL

1D
-0.72%
1M
-2.80%
YTD
20.58%
6M
18.52%
1Y
-29.01%
3Y*
-32.74%
5Y*
-25.30%
10Y*

ORI

1D
-0.24%
1M
-3.77%
YTD
-13.49%
6M
-9.97%
1Y
5.72%
3Y*
22.36%
5Y*
15.59%
10Y*
14.96%
*Multi-year figures are annualized to reflect compound growth (CAGR)

RCEL vs. ORI - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
RCEL
AVITA Medical, Inc.
20.58%-73.05%-6.71%107.88%-44.91%-35.52%-59.16%19.89%
ORI
Old Republic International Corporation
-13.49%37.50%27.10%26.32%6.68%44.92%-7.64%-3.20%

Correlation

The correlation between RCEL and ORI is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.04

Correlation (3Y)
Calculated over the trailing 3-year period

0.12

Correlation (5Y)
Calculated over the trailing 5-year period

0.18

Correlation (All Time)
Calculated using the full available price history since Oct 2, 2019

0.22

The correlation between RCEL and ORI shifts across timeframes, from 0.04 (1 year) to 0.22 (all time), reflecting how their relationship changes across market environments.

Fundamentals

EPS

RCEL:

-$0.46

ORI:

$5.45

PS Ratio

RCEL:

5.61

ORI:

0.74

Total Revenue (TTM)

RCEL:

$72.35M

ORI:

$9.37B

Gross Profit (TTM)

RCEL:

$58.86M

ORI:

$3.23B

EBITDA (TTM)

RCEL:

-$12.27M

ORI:

$911.00M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


AVITA Medical, Inc.

Return for Risk

RCEL vs. ORI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RCEL
RCEL Risk / Return Rank: 2727
Overall Rank
RCEL Sharpe Ratio Rank: 2727
Sharpe Ratio Rank
RCEL Sortino Ratio Rank: 3232
Sortino Ratio Rank
RCEL Omega Ratio Rank: 3232
Omega Ratio Rank
RCEL Calmar Ratio Rank: 2121
Calmar Ratio Rank
RCEL Martin Ratio Rank: 2424
Martin Ratio Rank

ORI
ORI Risk / Return Rank: 4646
Overall Rank
ORI Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
ORI Sortino Ratio Rank: 4141
Sortino Ratio Rank
ORI Omega Ratio Rank: 4242
Omega Ratio Rank
ORI Calmar Ratio Rank: 4949
Calmar Ratio Rank
ORI Martin Ratio Rank: 5151
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RCEL vs. ORI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for AVITA Medical, Inc. (RCEL) and Old Republic International Corporation (ORI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


RCELORIDifference
Sharpe ratioReturn per unit of total volatility

-0.57

Sortino ratioReturn per unit of downside risk

-0.39

Omega ratioGain probability vs. loss probability

1.01

1.06

-0.06

Calmar ratioReturn relative to maximum drawdown

-0.56

0.36

-0.92

Martin ratioReturn relative to average drawdown

-0.86

0.95

-1.81

RCEL vs. ORI - Sharpe Ratio Comparison

The current RCEL Sharpe Ratio is -0.32, which is lower than the ORI Sharpe Ratio of 0.25. The chart below compares the historical Sharpe Ratios of RCEL and ORI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


RCELORIDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.32

0.25

-0.57

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.34

0.71

-1.04

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.57

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.38

0.41

-0.79

Drawdowns

RCEL vs. ORI - Drawdown Comparison

The maximum RCEL drawdown since its inception was -94.08%, which is greater than ORI's maximum drawdown of -66.19%. Use the drawdown chart below to compare losses from any high point for RCEL and ORI.


Loading charts...

Drawdown Indicators


RCELORIDifference

Max Drawdown

Largest peak-to-trough decline

-94.08%

-66.19%

-27.89%

Max Drawdown (1Y)

Largest decline over 1 year

-51.63%

-16.18%

-35.45%

Max Drawdown (3Y)

Largest decline over 3 years

-84.27%

-16.18%

-68.09%

Max Drawdown (5Y)

Largest decline over 5 years

-85.15%

-20.36%

-64.79%

Max Drawdown (10Y)

Largest decline over 10 years

-47.78%

Current Drawdown

Current decline from peak

-92.46%

-15.31%

-77.15%

Average Drawdown

Average peak-to-trough decline

-72.24%

-14.54%

-57.70%

Ulcer Index

Depth and duration of drawdowns from previous peaks

33.76%

6.06%

+27.70%

Volatility

RCEL vs. ORI - Volatility Comparison

AVITA Medical, Inc. (RCEL) has a higher volatility of 18.37% compared to Old Republic International Corporation (ORI) at 5.41%. This indicates that RCEL's price experiences larger fluctuations and is considered to be riskier than ORI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


RCELORIDifference

Volatility (1M)

Calculated over the trailing 1-month period

18.37%

5.41%

+12.96%

Volatility (6M)

Calculated over the trailing 6-month period

47.96%

17.96%

+30.00%

Volatility (1Y)

Calculated over the trailing 1-year period

90.17%

22.82%

+67.35%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

74.89%

22.22%

+52.67%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

74.18%

26.12%

+48.06%

Dividends

RCEL vs. ORI - Dividend Comparison

RCEL has not paid dividends to shareholders, while ORI's dividend yield for the trailing twelve months is around 9.95%.


PositionTTM20252024202320222021202020192018201720162015
ORI
Old Republic International Corporation
9.95%6.92%2.93%3.33%7.95%13.75%4.26%8.05%8.65%3.55%3.95%3.97%
RCEL
AVITA Medical, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

RCEL vs. ORI - Financials Comparison

This section allows you to compare key financial metrics between AVITA Medical, Inc. and Old Republic International Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B2.00B2.50B20222023202420252026
19.25M
2.40B
(RCEL) Total Revenue
(ORI) Total Revenue
Values in USD except per share items

RCEL vs. ORI - Profitability Comparison

The chart below illustrates the profitability comparison between AVITA Medical, Inc. and Old Republic International Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%20222023202420252026
81.7%
0
Portfolio components
RCEL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AVITA Medical, Inc. reported a gross profit of 15.73M and revenue of 19.25M. Therefore, the gross margin over that period was 81.7%.

ORI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Old Republic International Corporation reported a gross profit of 0.00 and revenue of 2.40B. Therefore, the gross margin over that period was 0.0%.

RCEL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AVITA Medical, Inc. reported an operating income of 16.88M and revenue of 19.25M, resulting in an operating margin of 87.7%.

ORI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Old Republic International Corporation reported an operating income of 0.00 and revenue of 2.40B, resulting in an operating margin of 0.0%.

RCEL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AVITA Medical, Inc. reported a net income of -10.61M and revenue of 19.25M, resulting in a net margin of -55.1%.

ORI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Old Republic International Corporation reported a net income of 330.00M and revenue of 2.40B, resulting in a net margin of 13.8%.


Frequently Asked Questions


RCEL and ORI have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

RCEL has higher volatility (18.37%) compared to ORI (5.41%). In terms of maximum drawdown, RCEL dropped -94.08% vs ORI's -66.19%.

ORI currently has the higher Sharpe Ratio (0.25 vs -0.32), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for RCEL and ORI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer